The concept of industrial marijuana is hot. The pharmaceutical company plans to build extraction projects in the United States

[industry trends of pharmaceutical Station] in the evening of May 19, Rheinland biology announced that it planned to invest 402 million yuan in the construction of industrial hemp extraction and application engineering projects in the United States, further strengthen the business layout in the field of plant extraction, and improve the profitability of the main business At the same time, the company will also set up a wholly-owned U.S subsidiary layn hemp to be responsible for the implementation of the project According to the announcement, the project construction mainly involves the production capacity building of industrial hemp extraction plant and the R & D capacity building of the whole industrial chain including industrial hemp cultivation, production process and terminal application Specifically, it includes land purchase, civil construction, purchase and installation of production equipment, research and development of testing equipment and investment in fire-fighting and environmental protection facilities The main products of the project are hemp bisphenol (CBD crystal powder) and hemp full spectrum oil products, which can be used in many fields such as medical treatment, food additives, cosmetics and pet products According to the plan, the construction period of the project is 18 months, and it is expected to be completed and put into operation by the end of 2020 After the completion of the project, the annual capacity of raw materials is expected to be 5000 tons In fact, a month ago, Rhein biology released a notice that its wholly-owned US subsidiary layn USA and Bomar Agra estates, an industrial marijuana planting company in Colorado, LLC has entered into a high CBD hemp biomass product supply agreement for the supply of U.S Organic Certified industrial marijuana materials and its attachments The contract period is from April 15, 2019 to December 31, 2019 At that time, the announcement said that the signing of this contract created basic conditions for the company to carry out relevant research, process optimization, market testing, commercial negotiations and other aspects of industrial cannabis products Industrial hemp refers to the hemp varieties with less than 0.3% THC (tetrahydrocannabinol) and less than 0.3% toxicity The raw materials extracted from industrial hemp can be widely used in medicine, food, textile, construction and other fields Among them, CBD (cannabinoids) contained in industrial marijuana are widely used in medicine According to statistics, the global cannabis diphenol industry value will reach 5.7 billion US dollars in 2019 and 18.1 billion US dollars in 2021 From the end of last year to the beginning of this year, industrial leprosy rose in the domestic market, and many pharmaceutical enterprises took the lead in the field of industrial cannabis In addition to Rhine biology, Longjin pharmaceutical, Kangenbei, Zixin pharmaceutical, Yinhe biology, Huaren pharmaceutical, SELIS, Erkang pharmaceutical, Shouxian Valley and Kangenbei all have layout or intention to set foot in the field of industrial marijuana Zixin pharmaceutical disclosed the progress announcement of industrial marijuana industry on May 20, which showed that in order to meet the legal requirements of China's legally open areas of industrial marijuana, it was determined to introduce hemp seeds from FG company The seed line is fiber hemp, with CBD content of about 7% and THC content of less than 0.3% On May 18, 2019, the FG company's industrial hemp expert group handed over the hemp seed test certificate to the company in Liuhe County, Tonghua city The company or its wholly-owned subsidiary Jilin Zixin hemp R & D Co., Ltd will introduce the hemp seed into China through various ways as soon as possible According to the announcement, the imported seeds are very suitable for outdoor planting The hemp seeds and crops can not only meet the requirements of extracting CBD for medical use, but also can be used in textile, paper, food, health care products, etc In general, industrial marijuana is prevalent in China, but many enterprises are still waiting Since April 19, the industrial cannabis index has gradually cooled The industry believes that the current situation of industrial marijuana industry in the early stage of development in China can not be ignored, and its development prospects and directions are difficult to make accurate forecasts at present, so the layout of enterprises are also facing uncertainty risks, which need to be treated with caution.